PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vice Chancellor/Professor of Internal Medicine, University of Health Sciences, Lahore, Pakistan.\', \'Assistant Professor Public Health, University of Health Sciences, Lahore, Pakistan. shehnoor.azhar@gmail.com.\', \'Professor of Pharmacology, University of Health Sciences, Lahore, Pakistan.\', \'Data Analyst at University of Health Sciences, Lahore, Pakistan.\', \'Distinguished Investigator at Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-020-04616-4
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 32771032
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all